| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170819 (20R)-23,23-Difluoro-2-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs |
| 07/02/2009 | US20090170818 Arresting the proliferation of undifferentiated cells and inducing their differentiation; anticancer agents; treating psoriasis, wrinkles, slack skin, dry skin, insufficient sebum secretion, autoimmune disorders, inflammatory diseases, renal osteodystrophy. and obesity; little, if any, calcemic activity |
| 07/02/2009 | US20090170812 Transcription factor modulating compounds and methods of use thereof |
| 07/02/2009 | US20090170757 Methods of using macrocyclic modulators of the ghrelin receptor |
| 07/02/2009 | US20090170122 Human intestinal NPT2B |
| 07/02/2009 | US20090169563 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
| 07/02/2009 | CA2709727A1 Pharmaceutical composition for improving lower urinary tract symptoms |
| 07/02/2009 | CA2707447A1 Sulfonyl-substituted 6-membered ring derivative |
| 07/02/2009 | CA2706372A1 Crystalline polymorph of doxazosin mesylate (form iv) and process for preparation thereof |
| 07/01/2009 | EP2075582A2 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 07/01/2009 | EP2075002A2 Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence |
| 07/01/2009 | EP2074105A1 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 07/01/2009 | EP2074091A1 [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
| 07/01/2009 | EP2073806A2 Use of spiro-oxindole compounds as therapeutic agents |
| 07/01/2009 | EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1414428B1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 07/01/2009 | EP1406858B1 Substituted 4-aminocyclohexanols |
| 07/01/2009 | CN101468029A Difructose anhydride-containing composition and use thereof |
| 07/01/2009 | CN100506831C Phosphonic acid compounds as inhibitors of serine proteases |
| 07/01/2009 | CN100506815C Piperidinyl targeting compounds that selectively bind integrins |
| 07/01/2009 | CN100506791C Pentafluorosulfanylbenzoylguanidines, preparation method, their use as medicaments or diagnostic aids, and medicaments comprising them |
| 07/01/2009 | CN100506788C Arylalkylcarbamate derivatives production and use thereof in therapy |
| 07/01/2009 | CN100506776C NK1 antagonists |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 07/01/2009 | CN100506245C Hua Tuo kidney fortifying wine and its preparation method |
| 06/30/2009 | US7553928 Use of des-Aspartate-angiotensin I as an agent for the treatment and prevention of glomerulosclerosis and renal failure |
| 06/30/2009 | US7553867 Furan or thiophene derivative and medicinal use thereof |
| 06/30/2009 | US7553852 Caspase inhibitors and uses thereof |
| 06/30/2009 | US7553663 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 06/30/2009 | US7553660 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 06/30/2009 | US7553644 Detection and treatment of polycystic kidney disease |
| 06/30/2009 | US7553500 6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol (laxofoxifene); a prodrug with a glidant, disintegrant, lubricant and diluent/filler in given amounts; unit dosage forms, including low dosage forms; selective estrogen receptor modulators |
| 06/30/2009 | CA2295101C Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and renal function |
| 06/30/2009 | CA2161445C Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 06/25/2009 | WO2009078481A1 Bicyclic heterocyclic derivative |
| 06/25/2009 | WO2009078432A1 1-alkyl-4-amino-1h-pyrazole-3-carboxamide compound |
| 06/25/2009 | WO2009078423A1 Fused tricyclic compound having aldose reductase inhibitory activity |
| 06/25/2009 | WO2009077584A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands |
| 06/25/2009 | WO2009077371A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists |
| 06/25/2009 | WO2009077366A1 Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists |
| 06/25/2009 | WO2009027994A4 NOVEL STEROIDAL ESTERS OF 17-OXIMINO-5-ANDROSTEN-3β-OL |
| 06/25/2009 | WO2008046084A3 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 06/25/2009 | US20090163584 Therapeutic agent for renal failure |
| 06/25/2009 | US20090163571 Pharmaceutical for use in the treatment of ureterolithiasis |
| 06/25/2009 | US20090163556 Glycinamide derivatives as raf-kinase inhbitors |
| 06/25/2009 | US20090163542 5-ht7 receptor antagonists |
| 06/25/2009 | US20090163472 Mineralocorticoid receptor antagonists and methods of use |
| 06/25/2009 | US20090162434 Mesalazine tablet |
| 06/25/2009 | US20090162433 Method of treatment |
| 06/25/2009 | US20090162411 Encapsulated kidney tissue |
| 06/25/2009 | CA2709135A1 Treatment of interstitial cystitis |
| 06/25/2009 | CA2708866A1 Bicyclic heterocyclic derivative |
| 06/25/2009 | CA2708228A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists |
| 06/25/2009 | CA2707422A1 Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists |
| 06/24/2009 | EP2072522A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 06/24/2009 | EP2072519A1 Diaryl ketimine derivative |
| 06/24/2009 | EP2072046A1 Use of a hydrocarbon-containing preparation for preventing or treating cardiac-circulatory diseases, diabetes, osteoporosis and chronic liver failure |
| 06/24/2009 | EP1713769B1 Amorphous tamsulosin hydrochloride |
| 06/24/2009 | CN101461804A (+)-1-(3,4-dichlorrophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 06/24/2009 | CN100503608C Deazapurines and uses thereof |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503572C Caspase inhibitors and uses thereof |
| 06/24/2009 | CN100503570C Cyanoguanidine prodrugs |
| 06/24/2009 | CN100502900C Astragalus root dripping pill and its preparing method |
| 06/24/2009 | CN100502873C Formulations containing cephalosporin |
| 06/23/2009 | USRE40792 treating CANCER, PMS, MENOPAUSE AND HYPERCHOLESTEROLEMIA with plant extract of soya or clover and isoflavones from Genistein, Daidzein, Biochanin A, Formononetin or the natural glycosides; dosage forms |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550476 Condensed polycyclic compounds |
| 06/23/2009 | US7550475 Use of phosphodiesterase 4 inhibitors such as 6,7-dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene to treat asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550469 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/23/2009 | US7550464 Use of phosphodiesterase 4 inhibitors such as 8,9-dimethoxy-6-phenyl-1,3,4,6,11,11a-hexahydro-2H -pyrazino[1,2-b]isoquinoline for treating asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | CA2492804C Novel inhibitors of kinases |
| 06/23/2009 | CA2347506C Quinazolinone derivatives |
| 06/23/2009 | CA2208078C Formulations and methods for reducing skin irritation |
| 06/18/2009 | WO2009076663A1 Method and composition for treating an alpha adrenoceptor-mediated condition |
| 06/18/2009 | WO2009075349A1 Element retained in blood showing degradability selectively in tumor tissue |
| 06/18/2009 | WO2009074674A2 Trisubstituted piperidines as renin inhibitors |
| 06/18/2009 | US20090156803 Condensed furan compounds |
| 06/18/2009 | US20090156671 Deuterium-enriched oxybutynin |
| 06/18/2009 | US20090156640 Nociceptin analogs |
| 06/18/2009 | US20090155281 Methods of using antibodies that bind both bcma and taci |
| 06/18/2009 | US20090155245 Treatment for Organ Regeneration with Combination of Drug and Biologics |
| 06/18/2009 | US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa |
| 06/18/2009 | CA2845454A1 Organic compounds useful as inhibitors of phosphodiesterase 1 |
| 06/18/2009 | CA2709103A1 Method and composition for treating an alpha adrenoceptor-mediated condition |
| 06/18/2009 | CA2708570A1 Organic compounds |
| 06/17/2009 | EP2070930A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 06/17/2009 | EP2070921A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 06/17/2009 | EP2070919A1 Spiroquinone compound and pharmaceutical composition |
| 06/17/2009 | EP2070914A1 New antagonist derivatives of the vitronectin receiver, method for preparing same, application of same as medicine and pharmaceutical compositions containing them |
| 06/17/2009 | EP1485375B1 Pyrimidine compounds |
| 06/17/2009 | EP1357115B1 Alkanoic acid derivatives, process for their production and use thereof |
| 06/17/2009 | EP1337518B1 Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor |
| 06/17/2009 | CN100500200C Fuyankang pills against gynecologic inflammation and their preparation |
| 06/17/2009 | CN100500193C Extract from decoction of rehmannia including six elements, combination of medication, and medical use |
| 06/17/2009 | CN100500134C Preparation for improving bioavailability and effect of golden pheasant and preparation method and purpose thereof |
| 06/16/2009 | US7547802 Compounds for the treatment of metabolic disorders |
| 06/16/2009 | US7547728 (N-(4-nitro-3-trifluoromethyl)phenyl)-(2S)-3-(4- (acetylamino) phenoxy)-2-hydroxy-2-methylpropanamide) derivatives |